RxSight Inc (RXST): Kapitalisasi marang pendapatan
RxSight, Inc. (RXST) is developing a niche in Light Adjustable Lenses (LAL), which surgeons can fine-tune with a laser post-implantation. The business's profitability relies on the supply of innovative ophthalmological systems. The P/S ratio timeline demonstrates the market valuation of revenue, where the 1.80 mark reflects the latest data. Rapid demand for adjustable lenses is accelerating capital turnover, although current quotes already price in investor optimism.
Rincian analitis perusahaan RxSight Corp (RXST)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal RxSight, Inc.|RXST - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas RxSight Ophthalmic|RXST - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku RxSight Corp|RXST - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan RxSight|Rasio jangkoan perantara rxsight.com
- data bathi lan kelipatan valuasi:
RXST - Bathi resik|Bathi resik sing dikarepake RxSight, Inc.|RXST - Rasio rega marang bathi|Pangali forward rega marang bathi RxSight Inc|RXST - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA RxSight Corp|RXST - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan RxSight|RXST - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan rxsight.com|RXST - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep RxSight, Inc.
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:RXST rxsight.com
The P/S multiple reflects the market value of RxSight, Inc. (RXST) relative to its annual revenue, allowing for an assessment of the premium investors are willing to pay per unit of sales. By analyzing the current P/S level, one can determine the fairness of the asset's valuation, considering the business's protection via light system patents and high FDA certification barriers that limit competition in cataract surgery.
Pesaing RxSight, Inc.
BSX (bostonscientific.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Edwards Lifesciences Corporation EW|RMD - Kapitalisasi marang pendapatan|OmniPod - Multiplikator P/S|Rega marang dodolan Zimmer Biomet Holdings|COO: Multiplikator P/S|Rasio kapitalisasi marang pendapatan ALGN|GMED (Globus Medical) - Multiplikator P/S|TransMedics Group Inc (TMDX) - Koefisien rega marang pendapatan|Multiplikator P/S ATEC|Kapitalisasi marang pendapatan Artivion Corp AORT|Multiplikator P/S ENOV (Enovis Corporation)|Multiplikator P/S integralife.com IART|ESTA - Rasio rega marang pendapatan|BBNX: Rasio rega marang pendapatan|IRMD (Iradimed) - Kapitalisasi marang pendapatan|Embecta Health - Rasio kapitalisasi pasar marang pendapatan|TNDM (Tandem Diabetes Care) - Multiplikator P/S|Rega marang dodolan axogeninc.com AXGN|Rasio rega marang pendapatan SI-BONE (SIBN)|Orthofix Medical (OFIX) - Multiplikator rega marang pendapatan|Bioventus Corp - Kapitalisasi marang pendapatan|Multiplikator P/S OrthoPediatrics Corp KIDS|Treace Medical Concepts - Multiplikator P/S|Koefisien rega marang pendapatan blade.com SRTA|Carlsmed (CARL) - Rasio rega marang pendapatan|Rasio rega marang dodolan CLPT (ClearPoint Neuro)|Rasio rega marang pendapatan Stereotaxis Corp|Kapitalisasi marang pendapatan Neuronetics, Inc (STIM)|Multiplikator P/S SGHT|OBIO - Rega marang dodolan|Rasio rega marang pendapatan Anika Therapeutics, Inc. ANIK|NSPR: Rasio kapitalisasi marang pendapatan|ZJYL: Kapitalisasi marang pendapatan|Vivani Medical, Inc. - Kapitalisasi marang volume dodolan|xtantmedical.com (XTNT) - Rasio rega marang pendapatan|n1mtc.com - Rasio kapitalisasi pasar marang pendapatan|Kapitalisasi marang pendapatan MODD|Rasio kapitalisasi marang pendapatan MYO (Myomo Inc.)|Rasio rega marang pendapatan Envoy Medical, Inc (COCH)|Koefisien rega marang pendapatan Vivos Therapeutics Inc|Multiplikator P/S NVNO (enVVeno Medical)|Koefisien rega marang pendapatan Sintx Technologies Inc (SINT)|Tenon Medical - Multiplikator P/S|Multiplikator rega marang pendapatan ReWalk Robotics (LFWD)|AMIX: Multiplikator P/S|INVO Fertility Corp - Rasio kapitalisasi pasar marang pendapatan|Kapitalisasi marang pendapatan BBLG|AXNX (axonics.com) - Kapitalisasi marang volume dodolan|Kapitalisasi marang pendapatan BIOL (BIOLASE)|DYNT (dynatronics.com) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S FNA (Paragon 28)|Koefisien rega marang pendapatan INVO Bioscience Inc. (INVO)
